The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic was first
reported in Wuhan, China in December 2019, moved across the globe at an unprecedented …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is
responsible for the outbreak of coronavirus disease 19 (COVID-19) and was first identified in …

Objective Covid‐19 can involve multiple organs including the nervous system. We sought to
characterize the neurologic manifestations, their risk factors, and associated outcomes in …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …

Background Comprehensive data on the cerebrospinal fluid (CSF) profile in patients with
COVID-19 and neurological involvement from large-scale multicenter studies are missing so …

Background While much of the scientific focus thus far has been on cognitive sequelae in
patients with severe COVID‐19, subjective cognitive complaints are being reported across …

Considering the mechanisms capable of causing brain alterations in COVID-19, we aimed to
study the occurrence of cognitive abnormalities in the months following hospital discharge …

The post-infection of COVID-19 includes a myriad of neurologic symptoms including
neurodegeneration. Protein aggregation in brain can be considered as one of the important …

Coronaviruses, seven of which are known to infect humans, can cause a spectrum of clinical
presentations ranging from asymptomatic infection to severe illness and death. Four human …

Abstract Background In December 2019, unexplained cases of pneumonia emerged in
Wuhan, China, which were found to be secondary to the novel coronavirus SARS-CoV-2. On …